Showing 1 - 4 results of 4 for search 'Mariano Provencio Pulla', query time: 0.03s Refine Results
  1. 1
    Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications

    Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications by Luis de la Cruz-Merino, Marylène Lejeune, Esteban Nogales Fernández, Fernando Henao Carrasco, Ana Grueso López, Ana Illescas Vacas, Mariano Provencio Pulla, Cristina Callau, Tomás Álvaro

    Published 2012-01-01
    Get full text
    Article
  2. 2
    Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D

    Obesity and overweight in R/R DLBCL patients is associated with a better response to treatment of R2-GDP-GOTEL trial. Potential role of NK CD8 + cells and vitamin D by Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, Carlos Jiménez-Cortegana, Esteban Nogales-Fernández, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Eduardo Ríos-Herranz, Josep Gumà-Padrò, Mariano Provencio-Pulla, Antonio Rueda-Domínguez, Luis de la Cruz-Merino, Víctor Sánchez-Margalet

    Published 2025-03-01
    Get full text
    Article
  3. 3
    P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY

    P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY by Judith Trotman, Pier Luigi Zinzani, Jiri Mayer, Chris Flowers, Fontanet Bijou, Ana Carla Oliveira, Kamal Bouabdallah, Rod Johnson, Alejandro Martin Garcia-Sancho, Mariano Provencio Pulla, Marek Trneny, Hervé Tilly, Wojciech Jurczak, Elena Ivanova, Pil Kim, Adam Greenbaum, Sha Huang, Richard Delarue, Rebecca Auer

    Published 2023-08-01
    Get full text
    Article
  4. 4
    CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

    CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma by Lourdes Hontecillas-Prieto, Lourdes Hontecillas-Prieto, Lourdes Hontecillas-Prieto, Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, Daniel J. García-Domínguez, Natalia Palazón-Carrión, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, María L. Sánchez-León, Silvia Silva-Romeiro, Rocío Flores-Campos, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà-Padrò, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez-Carvajal, Jorge Labrador, María Guirado-Risueño, Mariano Provencio-Pulla, Margarita Sánchez-Beato, Lejeune Marylene, Tomás Álvaro-Naranjo, María Casanova-Espinosa, Antonio Rueda-Domínguez, Víctor Sánchez-Margalet, Víctor Sánchez-Margalet, Víctor Sánchez-Margalet, Luis de la Cruz-Merino, Luis de la Cruz-Merino, Luis de la Cruz-Merino

    Published 2024-02-01
    Get full text
    Article

Search Tools: